查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941102

疤痕管理市場 - 全球產業規模、佔有率、趨勢、機會及預測（按疤痕類型、產品、最終用途、地區和競爭格局分類，2021-2031年）

Scar Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Scar Type, By Product, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球疤痕管理市場預計將從 2025 年的 17.1 億美元成長到 2031 年的 22.7 億美元，複合年成長率為 4.83%。

該市場涵蓋多種治療方案，包括注射、雷射治療和外用矽膠貼片，旨在改善創傷、燒燙傷或手術造成的疤痕外觀。推動這一市場成長的主要因素是皮膚損傷後美容和重組手術的增加，以及社會對外觀日益成長的關注，這直接增加了對有效術後護理的需求。國際美容整形外科學會 (ISAPS) 的數據也支持這一趨勢，該學會指出，疤痕修復術在 2024 年將成為全球五大美容外科手術之一。

市場概覽
預測期 2027-2031
市場規模：2025年 17.1億美元
市場規模：2031年 22.7億美元
複合年成長率：2026-2031年 4.83%
成長最快的細分市場 增生性瘢痕和瘢痕疙瘩
最大的市場 北美洲

儘管成長潛力巨大，但先進治療方法的高昂費用卻成為市場擴張的一大障礙。諸如手術修復和雷射治療等高成本方案通常被歸類為美容而非醫療，因此不包含在標準保險報銷計劃內。這種經濟障礙限制了患者的就醫途徑，阻礙了高品質治療方案的廣泛應用，尤其是在對費用高度敏感的地區，高額的自付費用會抑制患者使用這些專業療法。

市場促進因素

燒燙傷和創傷病例的不斷增加是市場成長的主要動力，也因此迫切需要有效的治療性介入來解決外觀畸形和功能障礙。嚴重燒傷通常會導致攣縮和增生性疤痕，持續推動全球對先進治療方案（例如壓力衣和矽膠片）的需求。美國國立衛生研究院 (NIH) 於 2025 年 8 月發布的題為《按地區和國家分類的全球燒傷負擔》的研究報告凸顯了這一醫療需求的規模。該研究估計全球嚴重燒傷患者人數高達 1,299 萬，顯示龐大的患者群體需要專門的局部用藥製劑來最佳化傷口癒合和長期復健護理。

同時，消費者對恢復時間短、併發症發生率低的治療方法的偏好，正推動著非侵入性和微創治療方法的興起，重塑著市場格局。這一趨勢加速了注射和雷射治療方法的普及，這些治療方式無需進行修復手術即可有效改善疤痕。根據美國整形外科醫師協會於2025年6月發布的《2024年手術統計報告》，2024年將進行超過370萬例皮膚修復手術，顯示非手術年輕化療法正迅速普及。此外，皮膚疾病的持續高發也進一步擴大了潛在市場。正如美國皮膚病學會2025年指出的那樣，痤瘡每年影響多達5000萬美國人，這顯著增加了對萎縮性疤痕治療的需求。

市場挑戰

高昂的治療方法費用和保險覆蓋範圍的不足是限制全球疤痕管理市場成長的重要因素。保險公司通常將高級治療性介入，尤其是雷射治療和手術修復，歸類為美容項目而非醫療必需項目。這種分類使得這些項目無法獲得標準報銷，迫使患者自費承擔昂貴的治療費用。因此，高品質的疤痕管理方案主要局限於高收入人群，阻礙了市場惠及大量需要治療但無力負擔自費費用的患者群體。

這種經濟壁壘造成了臨床需求與市場可近性之間的巨大差距，有效地限制了醫療設備製造商和服務提供者的收入潛力。依賴患者自費支付阻礙了有效治療方法的廣泛應用，並將市場擴張主要限制在富裕的已開發國家。國際美容整形外科學會 (ISAPS) 的數據清楚地顯示了這些成本對市場獨佔性的影響。該學會預測，到 2024 年，全球將進行約 1,156,446 例疤痕修復手術。雖然數量可觀，但這僅佔潛在市場的一小部分，因為高成本使得全球相當一部分遭受創傷或術後疤痕困擾的人群無法尋求專業治療。

市場趨勢

人工智慧驅動的疤痕評估技術的出現，正以客觀、數據驅動的洞察取代主觀評估，徹底改變臨床決策。這些平台利用機器學習演算法分析傷口深度和癒合模式，使醫療專業人員能夠針對複雜的皮膚疾病精準制定治療方案，並在適當的時機進行干預。 Swift Medical 就是這數位轉型的典型案例。該公司在 2024 年 1 月發布的資金籌措中宣布，已資金籌措800 萬美元用於其人工智慧平台的開發。該平台利用超過 2000 萬張傷口影像來最佳化臨床評估。

同時，幹細胞療法與再生醫學的融合標誌著疤痕治療從被動管理轉向主動生物修復。自體細胞採集等先進技術透過將前驅細胞直接輸送到受損區域，促進天然皮膚結構的再生，從而最大限度地減少纖維化和攣縮的形成。這種方法也引起了商業性的廣泛關注。根據Avita Medical於2024年11月發布的“2024年第三季財務業績報告”，該公司再生醫學技術RECELL的商業收入達到1950萬美元，同比成長44%，這主要得益於其在皮膚修復領域的應用拓展。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球疤痕管理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依瘢痕類型（萎縮性瘢痕、增生性/瘢痕疙瘩瘢痕、其他）
    • 細分產品（矽凝膠/噴霧、矽敷料、乳霜/軟膏、其他）
    • 依申請方式（醫院、門診手術中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美疤痕管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲疤痕管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區疤痕管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲疤痕管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲疤痕管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球疤痕管理市場：SWOT分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Advancis Medical
  • Bayer AG
  • B. Braun SE
  • Bio Med Sciences, Inc.
  • Covalon Technologies Ltd.
  • Derma E
  • MOlnlycke Health Care AB
  • Newmedical Technology Inc.
  • Quantum Health
  • Smith & Nephew

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19429

The Global Scar Management Market is projected to expand from a valuation of USD 1.71 Billion in 2025 to reach USD 2.27 Billion by 2031, registering a compound annual growth rate of 4.83%. This market encompasses a diverse range of therapeutic solutions, including injectables, laser therapies, and topical silicone sheets, all aimed at improving the appearance of scars caused by trauma, burns, or surgeries. A key factor driving this growth is the rising volume of aesthetic and reconstructive surgeries necessitated by skin injuries and a growing societal emphasis on physical appearance, which directly increases the demand for effective post-operative care. This trend is substantiated by data from the International Society of Aesthetic Plastic Surgery (ISAPS), which identified scar revision as one of the top five surgical cosmetic procedures globally in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.71 Billion
Market Size 2031USD 2.27 Billion
CAGR 2026-20314.83%
Fastest Growing SegmentHypertrophic and Keloid Scars
Largest MarketNorth America

Despite this growth potential, market expansion is significantly hindered by the prohibitive costs associated with advanced treatment modalities. High-cost options such as surgical revisions and laser therapies are frequently categorized as cosmetic rather than medical, resulting in their exclusion from standard insurance reimbursement plans. This financial barrier restricts patient access and limits the widespread adoption of premium management solutions, particularly in cost-sensitive regions where high out-of-pocket expenses discourage the utilization of these specialized treatments.

Market Driver

The increasing prevalence of burns and traumatic injuries serves as a primary catalyst for market growth, creating an urgent need for robust therapeutic interventions to address aesthetic disfigurement and functional impairments. Severe thermal injuries often lead to contractures or hypertrophic scars, driving the sustained global demand for advanced management solutions such as pressure garments and silicone sheets. The scale of this medical necessity is highlighted by a National Institutes of Health study titled 'Global, Regional, and National Burden of Burn Injury' from August 2025, which estimated the global prevalence of severe burns at 12.99 million, thereby creating a substantial patient base requiring specialized topical formulations and extended post-acute care to optimize wound maturation.

Simultaneously, the market is being reshaped by a shift toward non-invasive and minimally invasive therapies, driven by consumer preference for procedures that offer reduced recovery times and lower complication rates. This trend has accelerated the adoption of injectable agents and laser-based modalities that provide effective scar remodeling without the invasiveness of surgical revision. According to the American Society of Plastic Surgeons' '2024 Procedural Statistics Report' released in June 2025, over 3.7 million skin resurfacing procedures were performed in 2024, reflecting the surging popularity of non-surgical rejuvenation. Additionally, the persistent burden of dermatological conditions further expands the addressable market; as noted by the American Academy of Dermatology in 2025, acne affects up to 50 million Americans annually, significantly contributing to the demand for atrophic scar treatments.

Market Challenge

The growth of the Global Scar Management Market is significantly hampered by the prohibitive costs of advanced treatment modalities and a widespread lack of insurance reimbursement. Insurance providers frequently classify advanced therapeutic interventions, particularly laser treatments and surgical revisions, as cosmetic rather than medically necessary. This classification leads to their exclusion from standard reimbursement schemes, forcing patients to bear the full financial burden of these expensive procedures. Consequently, the adoption of premium management solutions is largely restricted to individuals with higher disposable incomes, preventing the market from capitalizing on the vast number of patients who require treatment but cannot afford the out-of-pocket expenses.

This financial barrier creates a sharp divide between clinical need and market accessibility, effectively capping potential revenue for device manufacturers and service providers. The reliance on patient self-funding discourages the widespread utilization of effective therapies, limiting market expansion primarily to developed nations with wealthier patient demographics. The impact of these costs on market exclusivity is evident in data from the International Society of Aesthetic Plastic Surgery (ISAPS), which reported approximately 1,156,446 scar revision procedures globally in 2024; while substantial, this volume represents only a fraction of the total addressable market, as high costs deter a significant portion of the global population suffering from traumatic or post-surgical scars from seeking professional management.

Market Trends

The emergence of AI-driven scar assessment technologies is revolutionizing clinical decision-making by replacing subjective evaluations with objective, data-driven insights. These platforms utilize machine learning algorithms to analyze wound depth and healing patterns, enabling practitioners to tailor therapeutic regimens with precision and ensure timely interventions for complex dermatological conditions. This digital transformation is exemplified by Swift Medical, which, according to its January 2024 press release regarding a new financing round, secured $8 million to enhance its AI-powered platform that leverages over 20 million wound images to optimize clinical assessments.

Concurrently, the integration of stem cell therapies and regenerative medicine represents a shift from passive scar management to active biological repair. Advanced modalities, such as autologous cell harvesting, facilitate the regeneration of natural skin architecture by delivering progenitor cells directly to injury sites, thereby minimizing fibrosis and contracture formation. This approach is gaining significant commercial traction, as evidenced by Avita Medical's 'Third Quarter 2024 Financial Results' from November 2024, which reported that commercial revenue for its regenerative RECELL technology reached $19.5 million, marking a 44% increase compared to the previous year due to expanded usage in skin restoration.

Key Market Players

  • Advancis Medical
  • Bayer AG
  • B. Braun S.E.
  • Bio Med Sciences, Inc.
  • Covalon Technologies Ltd.
  • Derma E
  • MOlnlycke Health Care AB
  • Newmedical Technology Inc.
  • Quantum Health
  • Smith & Nephew

Report Scope

In this report, the Global Scar Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Scar Management Market, By Scar Type

  • Atrophic Scars
  • Hypertrophic and Keloid Scars
  • Others

Scar Management Market, By Product

  • Silicone Gel and Spray
  • Silicon Dressing
  • Cream and Ointment
  • Others

Scar Management Market, By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Scar Management Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Scar Management Market.

Available Customizations:

Global Scar Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Scar Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Scar Type (Atrophic Scars, Hypertrophic and Keloid Scars, Others)
    • 5.2.2. By Product (Silicone Gel and Spray, Silicon Dressing, Cream and Ointment, Others)
    • 5.2.3. By End-use (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Scar Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Scar Type
    • 6.2.2. By Product
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Scar Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Scar Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Scar Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Scar Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Scar Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Scar Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End-use

7. Europe Scar Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Scar Type
    • 7.2.2. By Product
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Scar Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Scar Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Scar Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Scar Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Scar Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Scar Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Scar Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Scar Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Scar Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Scar Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End-use

8. Asia Pacific Scar Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Scar Type
    • 8.2.2. By Product
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Scar Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Scar Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Scar Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Scar Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Scar Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Scar Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Scar Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Scar Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Scar Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Scar Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Scar Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Scar Type
    • 9.2.2. By Product
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Scar Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Scar Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Scar Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Scar Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Scar Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Scar Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End-use

10. South America Scar Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Scar Type
    • 10.2.2. By Product
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Scar Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Scar Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Scar Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Scar Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Scar Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Scar Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Scar Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Advancis Medical
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bayer AG
  • 15.3. B. Braun S.E.
  • 15.4. Bio Med Sciences, Inc.
  • 15.5. Covalon Technologies Ltd.
  • 15.6. Derma E
  • 15.7. MOlnlycke Health Care AB
  • 15.8. Newmedical Technology Inc.
  • 15.9. Quantum Health
  • 15.10. Smith & Nephew

16. Strategic Recommendations

17. About Us & Disclaimer